FDA Issues Boxed Warning for Increased Risk of Death with Febuxostat and Allopurinol Recently, the Food and Drug Administration (FDA) has added a boxed warning to the prescribing information for febuxostat and allopurinol, commonly used to treat patients with gout. This warning highlights the increased risk of heart-related death and death from all causes associated…